ADORA2B and head and neck squamous cell carcinoma: Solid tumors contain high levels of exogenous immune-suppressive ADO [13, 14], and the inhibition of the adenosine receptor A2B (ADORA2B) signaling leads to a decreased proliferation of human HNSCC cells, in vitro [15].